ÂÜŔňÂŇÂ×

Sara Worrell currently serves as the Director of Business Development at Illingworth Research Group, a role assumed in October 2022, focusing on patient-centered clinical services for the pharmaceutical and healthcare sectors. With a robust background in business development, Sara held similar leadership positions at Curebase and Health Decisions, where efforts concentrated on advancing women’s health products. Previous experience includes roles at Rho, George Clinical, SGS, PPD, INC Research, MedQuest Associates, and Meda Pharmaceuticals, showcasing expertise in building client relationships and driving revenue growth across various healthcare and pharmaceutical domains. Sara Worrell holds a Bachelor’s Degree in Physical Education with a Minor in Business Leadership from the University of North Carolina Wilmington and a certification in Medical Terminology.